At what enterprise value was SANTE CIE acquired in 2020?

During the acquisition of SANTE CIE by ARDIAN in 2020, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 15.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of SANTE CIE when it was acquired by ARDIAN?

The estimated EV/EBITDA multiple for SANTE CIE is in the range of 15x - 25x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 15.6x. Join our community for free to access full valuation data and industry trends.

When was SANTE CIE acquired by ARDIAN?

SANTE CIE was acquired by ARDIAN in 2020.

What was the revenue of SANTE CIE at the time of the deal?

The revenue of SANTE CIE at the time of the deal is estimated to be in the range of 150M - 250M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of SANTE CIE during the acquisition?

SANTE CIE's EBITDA is estimated to be in the range of 50M - 100M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the SANTE CIE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the SANTE CIE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.ardian.com/fr/communiques-de-presse/ardian-va-acquerir-une-participation-au-sein-du-groupe-sante-cie-aux-cotes

← DATABASE

Home Database Healthcare & PharmaSANTE CIE

01/2020

SANTE CIE acquired by ARDIAN

FRANCE Health Providers EV 500M - 1.5b EUR

Context

Ardian acquired a majority stake in Sante Cie from HLD and UI Gestion, who had controlled the company since 2015. Both HLD and UI Gestion reinvested significant capital alongside Ardian and the management team to support the next phase of growth. The transaction was designed to provide the group with the "firepower" to lead the consolidation of the fragmented French Home Healthcare market and to begin a pan-European expansion. The investment thesis focused on demographic tailwinds (aging population) and the structural shift in healthcare systems toward reducing hospital stays by favoring home-based medical support.

SANTE CIE, which reported an EBITDA margin of in 2019, is valued in this transaction at an EV/EBITDA multiple of , representing a level the average currently observed in the Healthcare & Pharma sector (15.6x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Sante Cie is the 3rd largest provider of home healthcare services (PSAD - Prestation de SanteaDomicile) in France. Through its networks, Elivie and Asdia, it supports over 150,000 patients annually across 80 agencies. It specializes in complex home treatments including perfusion, nutrition, insulin pumps, Parkinson s treatment, and respiratory assistance.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2019

2018

Similar deals in Health Providers

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
02/2020	VIVALTO VIE	SOLIMAR	SPAIN	Nursing Homes
02/2020	CLARIANE	INICEA	FRANCE	Clinics / Hospitals
01/2020	VIVALTO SANTÉ	MATHILDE MÉDICAL DÉVELOPPEMENT	FRANCE	Clinics / Hospitals
12/2019	CIRCLE HEALTH	BMI HEALTHCARE	UNITED KINGDOM	Clinics / Hospitals
07/2019	NAXICAP PARTNERS / ARDIAN	EMERA	FRANCE	Nursing Homes
07/2019	I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENT	DOMIDEP	FRANCE	Nursing Homes
07/2019	TRITON PARTNERS	ALERIS	SWEDEN	Clinics / Hospitals
04/2019	COLISÉE	ARMONEA	BELGIUM	Nursing Homes
03/2019	DOMUSVI	RESIDALYA	FRANCE	Nursing Homes
01/2019	HUMANA	CORONARIA HOIVA	FINLAND	Nursing Homes

REFERENCES

Valuation range: EV 500M - 1.5b EUR

Revenue range: 150M - 250M EUR

EBITDA range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SANTE CIE by ARDIAN are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Press release: view release

Target: sante cie

Acquirer: ardian